RecruitingAortic Arch AneurysmAortic Arch DissectionChronic Aortic Dissection
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
Eligible age
18–80 yrs
Accepts
All genders
Locations
15 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this clinical trial is to learn if the Arcevo LSA stent graft can safely and effectively treat patients that have an acute or chronic aortic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta.
Sponsor: Artivion Inc.
Where it's recruiting
Alabama
Birmingham
California
Los Angeles
Colorado
Aurora
District of Columbia
Washington D.C.
Florida
Gainesville
Georgia
Atlanta
Illinois
Chicago
Maryland
Baltimore
Michigan
Ann Arbor
New York
New York · The Bronx
Ohio
Cleveland
Pennsylvania
Philadelphia · Pittsburgh
Source: ClinicalTrials.gov · NCT07089576 · last updated 2026-10-15